Profile data is unavailable for this security.
About the company
GlaxoSmithKline Capital plc is a United Kingdom-based company. The principal activities of the Company are the issuance of notes under the GSK Group (Group) European medium term note program and the provision of financial services to other companies within the Group.
- Revenue in GBP (TTM)0.00
- Net income in GBP12.19m
- Incorporated1988
- Employees0.00
- LocationGLAXOSMSC 5.25% MTM EXP 10/04/42G S K House, 980 Great West RoadBRENTFORD TW8 9GSUnited KingdomGBR
- Phone+44 208 047 4509
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSF Enterprise PLC | 52.84k | -1.11m | 2.31m | 10.00 | -- | 0.8502 | -- | 43.73 | -0.0093 | -0.0093 | 0.0004 | 0.0212 | 0.0163 | 0.9496 | 4.07 | 5,284.00 | -34.25 | -35.35 | -37.51 | -38.06 | -34.37 | -- | -2,107.34 | -4,267.99 | 1.38 | -710.58 | 0.00 | -- | -8.61 | -- | 33.41 | -- | -- | -- |
| Nuformix PLC | 0.00 | -652.59k | 5.38m | 3.00 | -- | 6.86 | -- | -- | -0.0004 | -0.0004 | 0.00 | 0.0004 | 0.00 | -- | -- | -- | -65.61 | -- | -88.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 82.08 | -- | -- | -- |
| CRISM' Therapeutics Corp | 25.00k | -1.49m | 6.98m | 0.00 | -- | 4.05 | -- | 279.37 | -0.0458 | -0.0469 | 0.0008 | 0.0333 | 0.012 | -- | 0.0305 | -- | -71.61 | -9.33 | -88.05 | -9.68 | 72.00 | -- | -5,952.00 | -32,053.62 | -- | -- | 0.00 | -- | -- | -- | 69.17 | -- | -41.03 | -- |
| GlaxoSmithKline Capital plc | 0.00 | 12.19m | 9.67m | 0.00 | 0.7931 | 0.0639 | -- | -- | 121.89 | 121.89 | 0.00 | 1,512.04 | 0.00 | -- | -- | -- | 0.1408 | 0.0973 | 0.1643 | 0.1147 | -- | -- | -- | -- | -- | -- | 0.9815 | -- | -- | -- | 1.61 | -1.35 | -- | -- |
| Probiotix Health PLC | 2.22m | -736.00k | 12.26m | 4.00 | -- | 6.85 | -- | 5.52 | -0.005 | -0.005 | 0.0146 | 0.0113 | 1.05 | 18.57 | 3.01 | 555,250.00 | -34.67 | -21.03 | -46.17 | -27.30 | 53.17 | 54.10 | -33.14 | -26.58 | 3.99 | -- | 0.00 | -- | 12.55 | 36.47 | -13.39 | -- | -41.50 | -- |
| Oxford Biodynamics PLC | 1.10m | -11.15m | 12.87m | 44.00 | -- | 5.26 | -- | 11.76 | -0.0096 | -0.0096 | 0.0008 | 0.0006 | 0.1085 | 2.22 | 1.21 | -- | -110.46 | -70.62 | -148.46 | -89.03 | 47.67 | -- | -1,018.54 | -1,715.57 | 0.8005 | -30.88 | 0.8208 | -- | 72.17 | 19.15 | 3.58 | -- | -11.79 | -- |
| CRUSHMETRIC Group Ltd | -100.00bn | -100.00bn | 20.71m | 17.00 | -- | 1.25 | -- | -- | -- | -- | -- | 0.068 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.027 | -- | 0.0898 | -- | -- | -- | -- | -- | -- | -- |
Data as of Jan 27 2026. Currency figures normalised to GLAXOSMSC 5.25% MTM EXP 10/04/42's reporting currency: UK Pound GBP
